Assessment of p16, p21, and p27 in granulocytic differentiation of human promyelocytic HL-60 cell line

Annals of the New York Academy of Sciences

Volumn 973, Issue , 2002, Pages 284-286

  Navakauskiene, Ruta ^a,b   Treigyte, Grazina ^a   Gineitis, Arunas ^a   Magnusson, Karl Eric ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Granulocytic differentiation; p16; p21; p27; RA

Indexed keywords

PROTEIN P16; PROTEIN P21; PROTEIN P27; RETINOIC ACID;

APOPTOSIS; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; PROMYELOCYTE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN ISOLATION;

EID: 0036959693     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04650.x     Document Type: Conference Paper

References (3)

1. FENAUX, P., C. CHOMIENNE & L. DEGOS. 2001. Treatment of acute promyelocytic leukaemia. Best Pract. Res. Clin. Haematol. 14: 153-174.
2. SHERR, C.J. & J.M. Roberts, 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13: 1501-1512.
3. LEE, M.H. & H.-Y. YANG. 2001. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell. Mol. Life Sci. 58: 1907-1922.